Nanodiamond as the pH‐Responsive Vehicle for an Anticancer Drug
Authors:
Abstract
Cis‐dichlorodiammineplatinum(II) (CDDP, cisplatin), a widely used anticancer drug, is successfully loaded onto nanodiamond (ND) by adsorption and complexation. The CDDP–ND composite is characterized by IR spectroscopy, atomic absorption spectroscopy, thermogravimetric analysis, energy‐dispersive X‐ray spectroscopy, and X‐ray photoelectron spectroscopy. CDDP is released from the composite in phosphate‐buffered saline (PBS) of pH 6.0 at a rate higher than in PBS of pH 7.4. Therefore, it is predicted that the ND vehicle would deliver low concentrations of CDDP in the blood, but release much more drug after integration into the acidic cytoplasm, thereby reducing toxic side effects. The complexation between CDDP and the carboxyl groups on the ND surface is responsible for the pH‐responsive release property. The drug released from the composite retains the same cytotoxicity as free CDDP against human cervical cancer cells.Keywords
This publication has 46 references indexed in Scilit:
- Using Detonation Nanodiamond for the Specific Capture of GlycoproteinsAnalytical Chemistry, 2008
- Synthesis of Porous Magnetic Hollow Silica Nanospheres for Nanomedicine ApplicationThe Journal of Physical Chemistry C, 2007
- Characterization and application of single fluorescent nanodiamonds as cellular biomarkersProceedings of the National Academy of Sciences, 2007
- Poly(γ,l-glutamic acid)–cisplatin conjugate effectively inhibits human breast tumor xenografted in nude miceBiomaterials, 2006
- Hart und weich: biofunktionalisierter DiamantAngewandte Chemie, 2006
- Bright Fluorescent Nanodiamonds: No Photobleaching and Low CytotoxicityJournal of the American Chemical Society, 2005
- Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticlesJournal of Controlled Release, 2005
- pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugateJournal of Controlled Release, 2004
- Clinical pharmacology of high-dose cisplatinCancer Chemotherapy and Pharmacology, 1985
- Daunorubicin-DNA: Further clinical trials in acute non-lymphoblastic leukemiaEuropean Journal of Cancer (1965), 1974